EODData

SHG, 600276: Jiangsu Hengrui Medicine Co Ltd

02 Dec 2025
LAST:

61.12

CHANGE:
 0.82
OPEN:
61.90
HIGH:
61.90
ASK:
0.00
VOLUME:
18.23M
CHG(%):
1.32
PREV:
61.94
LOW:
61.00
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Dec 2561.9061.9061.0061.1218.23M
01 Dec 2562.0862.0961.0661.9425.48M
28 Nov 2562.3662.3661.6162.0820.28M
27 Nov 2562.6062.9661.9462.0925.73M
26 Nov 2561.5062.8061.0362.3643.99M
25 Nov 2561.1061.6160.5360.8826.5M
24 Nov 2560.0461.1059.9660.6634.4M
21 Nov 2560.3361.1059.3159.5044.73M
20 Nov 2561.2361.6560.5460.6325.35M
19 Nov 2561.5061.7861.0261.1121.12M

PROFILE

Name:Jiangsu Hengrui Medicine Co Ltd
About:Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes drugs in China and internationally. The company develops antineoplastic drugs; surgery medications; medicines for oncology, autoimmune diseases, pain management, metabolic diseases, cardiovascular diseases, infectious diseases, respiratory system diseases, hematological diseases, neurological diseases, and ophthalmology, etc.; analgesia and anesthesia products; and contrast agents. It is also involved in technical consulting; training; investment advisory; technology development; project; information; and investing services, as well as the import and export of pharmaceutical products. The company has license agreement with GSK plc to develop up to 12 innovative medicines in respiratory, immunology and inflammation, and oncology areas. Jiangsu Hengrui Medicine Co., Ltd. was founded in 1970 and is headquartered in Lianyungang City, China.
Sector:Healthcare
Address:No. 38, Huanghe Road, Lianyungang City, China, 222000
Website:https://www.hengrui.com
ISIN:CNE0000014W7

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:53.38 
Forward P/E:60.71 
PEG Ratio:60.71 
Price to Sales:13.30 
Price to Book:6.94 
Profit Margin:0.24 
Operating Margin:0.21 
Return on Assets:0.08 
Return on Equity:0.14 
Revenue:30.983B 
EBITDA:8.246B 
Shares:6.379B 
Market Cap:389.884B 

TECHNICAL INDICATORS

MA5:61.921.3%
MA10:61.240.2%
MA20:61.670.9%
MA50:65.016.4%
MA100:63.674.2%
MA200:56.717.8%
STO9:46.82
STO14:36.82
RSI14:44.91
WPR14:-60.10
MTM14:-2.44
ROC14:-0.04 
ATR:1.27 
Week High:62.963.0%
Week Low:60.531.0%
Month High:64.996.3%
Month Low:59.317.8%
Year High:74.0421.1%
Year Low:42.4044.2%
Volatility:20.68 

RECENT SPLITS

Date Ratio
10 Jun 20211-1
25 May 20201-1
28 Mar 20191-1
30 May 20181-1
31 May 201712-10
16 Jun 201612-10
15 Jun 201513-10
15 May 201411-10
07 Jun 20131-1
29 May 201211-10

RECENT DIVIDENDS

Date Amount
23 May 2025$0.20
12 Jul 2024$0.20
08 Jun 2023$0.16
05 Jul 2022$0.16
10 Jun 2021$0.17
25 May 2020$0.16
28 Mar 2019$0.13
31 May 2017$0.04
16 Jun 2016$0.02
15 Jun 2015$0.01